Categories | Inventors
D4 Dopamine Receptor Knock-Out Mice
OHSU # 0379
Categories:
Inventors:
- Malcolm Low
- David Grandy, SM.Physiology & Pharmacology
- Marcelo Rubinstein
Technology
Overview
Researchers
at OHSU have developed a strain of mice that are genetically deficient in the D4
dopamine receptor. These mice
provide a new animal model for the study of the function of the D4
receptor. Homozygous mice may
exhibit locomotor supersensitivity to ethanol, cocaine, and methamphetamine, as
well as alterations in dopamine synthesis and function, glutamate levels and
metabolism, behavioral responses to novelty, and spontaneous locomotor activity
in both novel and familiar environments. They can also be used to study the
actions and specificity of newly discovered dopamine receptor agonists and
antagonists for treatment of numerous psychiatric conditions, addiction,
depression and other CNS-related diseases including Parkinson’s disease and
schizophrenia.
Breeding pairs are available which have been backcrossed 30 generations on the congenic C57BL/6J background.
Competitive
Environment
No
other D4 receptor knock-out mice are known to exist.
Inventor
Profiles
Malcolm
Low received his Ph.D. in Neuroscience from Tufts University in 1987. He earned
his B.S. from Rensselaer Polytechnic Institute and his M.D. from Albany Medical
College. He did an internship and residency at Michael Reese Hospital in Chicago
and then spent three years as a clinical and research fellow in
Neuroendocrinology at the New England Medical Center. From 1985 to 1989, Low
held concurrent positions on the faculty at Tufts and as a physician at the
Medical Center. He came to the Vollum Institute at OHSU in 1990 and was promoted
to scientist in 1994. He holds a joint appointment as professor in the
Department of Behavioral Neuroscience in the School of
Medicine.
David Grandy received his Ph.D. from Michigan State University in 1985. Dr. Grandy’s training was in both microbiology and molecular biology. For the last 25 years his research has focused on the cloning and deorphanization of G protein-coupled receptors (GPCRs) and the discovery of novel ligands for these receptors. Dr. Grandy is currently a Professor in the Physiology & Pharmacology Department at OHSU and joint appointment in the Department of Cell and Developmental Biology.
Selected
Publications
Rubinstein
et al. Cell 1997,
90(6):991-1001
Kruzich et al. Synapse 2004, 53(2):131-139
Thomas et al. J. Neurosci. Methods 2007, 166(2):306-314
Helms et al. Pharmacol Biochem Behav 2008, 90(3):387-393
Licensing
Opportunity
Breeding
pairs or cryopreserved embryos are available for non-exclusive
licensing.
For more information, contact:
Travis Cook
Technology Development Manager
503-494-3229
